4.2 Article

Vancomycin-Resistant Enterococci Epidemiology, Infection Prevention, and Control

期刊

出版社

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.idc.2016.07.009

关键词

VRE; Infection control; Enterococci; Health care-associated infections

资金

  1. Cubist
  2. Merck
  3. Theravance
  4. Pfizer
  5. Cerexa
  6. Tetraphase
  7. Cempra
  8. Melinta
  9. Paratek
  10. Rempex

向作者/读者索取更多资源

Vancomycin-resistant enterococci (VRE) infections have acquired prominence as a leading cause of health care associated infections. Understanding VRE epidemiology, transmission modes in health care settings, risk factors for colonization, and infection is essential to prevention and control of VRE infections. Infection control strategies are pivotal in management of VRE infections and should be based on patient characteristics, hospital needs, and available resources. Hand hygiene is basic to decrease acquisition of VRE. The effectiveness of surveillance and contact precautions is variable and controversial in endemic settings, but important during VRE outbreak investigations and control. Environmental cleaning, chlorhexidine bathing, and antimicrobial stewardship are vital in VRE prevention and control.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据